Oral18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: Demonstration of principle
Zoe Allen MartinezMark ColganLewis R. BaxterJavier QuintanaStefan SiegelArion F. ChatziioannouSimon R. CherryJohn C. MazziottaMichael E. Phelps
14
Citation
11
Reference
10
Related Paper
Citation Trend
Abstract:
We describe a method of orally administering 18F-fluoro-2-deoxyglucose (FDG) for positron emission tomography (PET) scans to determine local cerebral metabolic rates for glucose (LCMRGlc), normalized to that of whole brain, in fully conscious, non-restrained primates. Oral FDG-PET studies were performed in both non-restrained and chaired monkeys, and in one human where results could be compared with traditional intravenous FDG administration. The oral route of FDG administration gave images and whole brain-normalized PET LCMRGlc results comparable to those obtained by the intravenous route. This oral FDG-PET method may provide a useful means by which to obtain measures of LCMRGlcs for brain structures, relative to each other, in non-restrained, non-drugged primates in field and laboratory studies. This method might also have clinical applications for PET studies of children.Keywords:
Deoxyglucose
Deoxyglucose
Cite
Citations (8)
Deoxyglucose
Cite
Citations (0)
Positron emission tomography with (18)F-fluoro-2-deoxyglucose is an imaging technology that is demonstrating increasing utility in the evaluation of gastrointestinal malignancies.
Deoxyglucose
Positron emission
Gastrointestinal cancer
Cite
Citations (46)
Deoxyglucose
Positron emission
Cite
Citations (0)
Deoxyglucose
Positron emission
Cite
Citations (5)
Deoxyglucose
Identification
Cite
Citations (6)
Deoxyglucose
Cardiac PET
Cite
Citations (1)
Deoxyglucose
Cardiac sarcoidosis
Cardiac PET
Cardiac Imaging
Cite
Citations (131)
Deoxyglucose
Spore germination
Cite
Citations (3)
The authors developed and tested a method for the noninvasive quantification of the cerebral metabolic rate for glucose (CMRglc) using positron emission tomography (PET), 18F-fluoro-2-deoxyglucose, the Patlak method, and an image-derived input function. Dynamic PET data acquired 12 to 48 seconds after rapid tracer injection were summed to identify carotid artery regions of interest (ROIs). The input function then was generated from the carotid artery ROIs. To correct spillover, the early summed image was superimposed over the last PET frame, a tissue ROI was drawn around the carotid arteries, and a tissue time activity curve (TAC) was generated. Three venous samples were drawn from the tracer injection site at a later time and used for the spillover and partial volume correction by non-negative least squares method. Twenty-six patient data sets were studied. It was found that the image-derived input function was comparable in shape and magnitude to the one obtained by arterial blood sampling. Moreover, no significant difference was found between CMRglc estimated by the Patlak method using either the arterial blood sampling data or the image-derived input function.
Deoxyglucose
Partial volume
Cite
Citations (243)